Publisert 19.06.2018

US patent granted June 2018


June 19th 2018

USPTO has today announced granting of additional US patent on Regenics technology.

The patent is entitled: "CELLULAR EXTRACTS"

U.S. Patent No.: U.S. Patent No. 9,999,639 is granted from a

Continuation of U.S. Patent Application No. 15/131,198 filed on 18-Apr-2016. Patent expiration dateis September 8th, 2027.



Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.